Michael Brochstein

Recommended Articles

• Wartime's Unsung Heroes: Honoring Veteran Military Nurses

  The current world would not be how it existed if it had not gone through wars and battles. In fact, the world has gone through two major globally inflicted wars. The most recent, and hopefully the last, was the Second World War or famously known as World War II (WWII). The war had lasted for six...

• What Is Bronchopulmonary Dysplasia (BPD)?

  Bronchopulmonary DysplasiaPremature infants who have problems in their respiratory system have an increased risk of bronchopulmonary dysplasia (BPD), which is also called chronic lung disease. Bronchopulmonary dysplasia (BPD) can be a serious condition, which needs intensive treatment. This...

• How Can I Stop Snoring?

  Snoring can affect not only your sleep but also your family members and friends, if you sleep in the same room with them. Snoring can lead to sleep problems, fatigue during day, irritability, and other health problems. About 45% of adults in the world are affected by snoring, and it is more commonly...

• Medical Marijuana for Multiple Sclerosis Symptoms

  Multiple sclerosis experts in the UK say that people with the disease should be permitted to use cannabis to relieve their symptoms. The experts suggest that over nine thousand people should be allowed to use the drug.The MS Society states that one in ten multiple sclerosis patients have pain and...

• Nymphomania: Causes, Symptoms, Treatment, and Diagnosis

  Nymphomania is a mental disorder. The person shows characteristic compulsive sexual behavior. Compulsive means unwanted actions and rituals. The person repeatedly engages in it without getting any pleasure out of it, or the person is unable to control the behaviors. A person with nymphomania acts...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...